Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus

Molecular Immunology

Volumn 48, Issue 12-13, 2011, Pages 1397-1407

  Ingaramo, Paola I ^a   Ronco, María T ^a   Francés, Daniel E A ^a   Monti, Juan A ^a   Pisani, Gerardo B ^a   Ceballos, María P ^a   Galleano, Mónica ^b   Carrillo, María C ^a   Carnovale, Cristina E ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apoptosis; Caspase 3; Caspase 8; Diabetes; INOS; Insulin; JNK; Liver; NF B; TNF

Indexed keywords

AMINOGUANIDINE; CASPASE 3; CASPASE 8; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ELECTRON SPIN RESONANCE SPECTROSCOPY; GUANIDINES; IMMUNOGLOBULIN G; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 79957864582     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.03.015     Document Type: Article

References (73)

1. Alexandraki K.I., Piperi C., Ziakas P.D., Apostolopoulos N.V., Makrilakis K., Syriou V., amanti-Kandarakis E., Kaltsas G., Kalofoutis A. Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J. Clin. Immunol. 2008, 28:314-321.
2. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
3. Barneo L., Esteban M.M., Garcia-Pravia C., Diaz F., Marin B. Normalization of the altered liver function tests after islet transplantation in diabetic rats. Diabetes Metab. 1990, 16:284-289.
4. Begum N., Ragolia L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am. J. Physiol. Cell Physiol. 2000, 278:C81-C91.
5. Bi Y., Sun W.P., Chen X., Li M., Liang H., Cai M.Y., Zhu Y.H., He X.Y., Xu F., Weng J.P. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol. 2008, 45:167-178.
6. Boden G., She P., Mozzoli M., Cheung P., Gumireddy K., Reddy P., Xiang X., Luo Z., Ruderman N. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54:3458-3465.
7. Brune B., von K.A., Sandau K.B. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ. 1999, 6:969-975.
8. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999, 15:269-290.
9. Carnovale C.E., Marinelli R.A., Rodriguez Garay E.A. Bile flow decrease and altered bile composition in streptozotocin-treated rats. Biochem. Pharmacol. 1986, 35:2625-2628.
10. Carnovale C.E., Rodriguez Garay E.A. Reversible impairment of hepatobiliary function induced by streptozotocin in the rat. Experientia 1984, 40:248-250.
11. Carnovale C.E., Scapini C., Alvarez M.L., Favre C., Monti J., Carrillo M.C. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. J. Hepatol. 2000, 32:798-804.
12. Chen X., Ding W.X., Ni H.M., Gao W., Shi Y.H., Gambotto A.A., Fan J., Beg A.A., Yin X.M. Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injury. Mol. Cell Biol. 2007, 27:541-553.
13. Cottet S., Dupraz P., Hamburger F., Dolci W., Jaquet M., Thorens B. cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells. Diabetes 2002, 51:1805-1814.
14. Crisafulli C., Galuppo M., Cuzzocrea S. Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. Pharmacol. Res. 2009, 60:332-340.
15. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am. J. Cardiol. 2007, 99:15B-26B.
16. Davis K.L., Martin E., Turko I.V., Murad F. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 2001, 41:203-236.
17. Ding W.X., Yin X.M. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell Mol. Med. 2004, 8:445-454.
18. Du C., Guan Q., Diao H., Yin Z., Jevnikar A.M. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am. J. Physiol. Renal Physiol. 2006, 290:F1044-F1054.
19. Erroi A., Fantuzzi G., Mengozzi M., Sironi M., Orencole S.F., Clark B.D., Dinarello C.A., Isetta A., Gnocchi P., Giovarelli M. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 1993, 61:4356-4359.
20. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
21. Fernandes A.A., Novelli E.L., Okoshi K., Okoshi M.P., Di Muzio B.P., Guimaraes J.F., Fernandes J.A. Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed. Pharmacother. 2010, 64:214-219.
22. Foss N.T., Foss-Freitas M.C., Ferreira M.A., Cardili R.N., Barbosa C.M., Foss M.C. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients. Diabetes Metab. 2007, 33:439-443.
23. Frances D., Ronco M., Monti J., Ingaramo P., Pisani G., Parody J., Pellegrino J., Martin-Sanz P., Carrillo M., Carnovale C. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect. J. Endocrinol. 2010, 205:187-200.
24. Fries W., Muja C., Crisafulli C., Costantino G., Longo G., Cuzzocrea S., Mazzon E. Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. Int. J. Med. Sci. 2008, 5:169-180.
25. Fujioka S., Schmidt C., Sclabas G.M., Li Z., Pelicano H., Peng B., Yao A., Niu J., Zhang W., Evans D.B., Abbruzzese J.L., Huang P., Chiao P.J. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J. Biol. Chem. 2004, 279:27549-27559.
26. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 1994, 71:219-225.
27. Haidara M.A., Mikhailidis D.P., Rateb M.A., Ahmed Z.A., Yassin H.Z., Ibrahim I.M., Rashed L.A. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced type 1 diabetes. J. Diabetes Complications 2009, 23:130-136.
28. Harrison S.A. Liver disease in patients with diabetes mellitus. J. Clin. Gastroenterol. 2006, 40:68-76.
29. Henry Y., Ducrocq C., Drapier J.C., Servent D., Pellat C., Guissani A. Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur. Biophys. J. 1991, 20:1-15.
30. Hickey M.J., Sihota E., Amrani A., Santamaria P., Zbytnuik L.D., Ng E.S., Ho W., Sharkey K.A., Kubes P. Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues. FASEB J. 2002, 16:1141-1143.
31. Ho F.M., Lin W.W., Chen B.C., Chao C.M., Yang C.R., Lin L.Y., Lai C.C., Liu S.H., Liau C.S. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal. 2006, 18:391-399.
32. Hwang S.L., Liu I.M., Tzeng T.F., Cheng J.T. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia 2005, 48:767-775.
33. Iwasaki Y., Kambayashi M., Asai M., Yoshida M., Nigawara T., Hashimoto K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J. Diabetes Complications 2007, 21:56-62.
34. Jeschke M.G., Klein D., Bolder U., Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004, 145:4084-4093.
35. Jeschke M.G., Klein D., Thasler W.E., Bolder U., Schlitt H.J., Jauch K.W., Weiss T.S. Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol. Med. 2008, 14:11-19.
36. Kim J.Y., Lee S.H., Song E.H., Park Y.M., Lim J.Y., Kim D.J., Choi K.H., Park S.I., Gao B., Kim W.H. A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3. Cell Signal. 2009, 21:1758-1767.
37. Klainguti M., Aigner S., Kilo J., Eppenberger H.M., Mandinova A., Aebi U., Schaub M.C., Shaw S.G., Luscher T.F., Atar D. Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning. Basic Res. Cardiol. 2000, 95:308-315.
38. Kolb J.P. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia 2000, 14:1685-1694.
39. Kruidering M., Evan G.I. Caspase-8 in apoptosis: the beginning of " the end"? IUBMB. Life 2000, 50:85-90.
40. Lawlor M.A., Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J. Cell Sci. 2001, 114:2903-2910.
41. Li L., Zhang J., Jin B., Block E.R., Patel J.M. Nitric oxide upregulation of caspase-8 mRNA expression in lung endothelial cells: role of JAK2/STAT-1 signaling. Mol. Cell Biochem. 2007, 305:71-77.
42. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
43. Madar Z., Kalet-Litman S., Stark A.H. Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats. Pharmacology 2005, 73:106-112.
44. Madhusudan S., Muthuramalingam S.R., Braybrooke J.P., Wilner S., Kaur K., Han C., Hoare S., Balkwill F., Ganesan T.S. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. J. Clin. Oncol. 2005, 23:5950-5959.
45. Martin-Sanz P., Hortelano S., Callejas N.A., Goren N., Casado M., Zeini M., Bosca L. Nitric oxide in liver inflammation and regeneration. Metab. Brain Dis. 2002, 17:325-334.
46. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
47. 2+ with diethyldithiocarbamate or N-methyl-d-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: comparative investigations. Biochim. Biophys. Acta 1997, 1336:225-234.
48. Noh H., Ha H., Yu M.R., Kang S.W., Choi K.H., Han D.S., Lee H.Y. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron 2002, 90:78-85.
49. Obolenskaya M.Y., Vanin A.F., Mordvintcev P.I., Mulsch A., Decker K. EPR evidence of nitric oxide production by the regenerating rat liver. Biochem. Biophys. Res. Commun. 1994, 202:571-576.
50. Powell L.A., Warpeha K.M., Xu W., Walker B., Trimble E.R. High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells. J. Mol. Endocrinol. 2004, 33:797-803.
51. Rabkin S.W., Klassen S.S. Nitric oxide differentially regulates the gene expression of caspase genes but not some autophagic genes. Nitric Oxide 2007, 16:339-347.
52. Ricci C., Jong C.J., Schaffer S.W. Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can. J. Physiol. Pharmacol. 2008, 86:166-172.
53. Romagnoli M., Gomez-Cabrera M.C., Perrelli M.G., Biasi F., Pallardo F.V., Sastre J., Poli G., Vina J. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic. Biol. Med. 2010, 49:171-177.
54. Ronco M.T., Alvarez M.L., Monti J.A., Carrillo M.C., Pisani G.B., Lugano M.C., Carnovale C.E. Role of nitric oxide increase on induced programmed cell death during early stages of rat liver regeneration. Biochim. Biophys. Acta 2004, 1690:70-76.
55. Ronco M.T., Frances D., de Lujan A.M., Quiroga A., Monti J., Parody J.P., Pisani G., Carrillo M.C., Carnovale C.E. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci. 2007, 81:750-755.
56. Rosa S.C., Judas F., Lopes M.C., Mendes A.F. Nitric oxide synthase isoforms and NF-kappaB activity in normal and osteoarthritic human chondrocytes: regulation by inducible nitric oxide. Nitric Oxide 2008, 19:276-283.
57. Saccani S., Pantano S., Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters. J. Exp. Med. 2001, 193:1351-1359.
58. Sass G., Koerber K., Bang R., Guehring H., Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 2001, 107:439-447.
59. Stadler K., Jenei V., von B.G., Somogyi A., Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic. Biol. Med. 2003, 35:1240-1251.
60. Stichtenoth D.O., Frolich J.C. Nitric oxide and inflammatory joint diseases. Br. J. Rheumatol. 1998, 37:246-257.
61. Stockklauser-Farber K., Ballhausen T., Laufer A., Rosen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim. Biophys. Acta 2000, 1535:10-20.
62. Traub O., Van B.R. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. West J. Med. 1995, 162:439-445.
63. van den B.R., Haenen G.R., van den B.H., Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 2001, 86(Suppl. 1):S121-S127.
64. Wajant H. Death receptors. Essays Biochem. 2003, 39:53-71.
65. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
66. Wullaert A., Heyninck K., Beyaert R. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem. Pharmacol. 2006, 72:1090-1101.
67. Xi W., Satoh H., Kase H., Suzuki K., Hattori Y. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem. Biophys. Res. Commun. 2005, 332:200-205.
68. Xu R., Morales J.A., Muniyappa R., Skafar D.F., Ram J.L., Sowers J.R. Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures. Life Sci. 1999, 64:2451-2462.
69. Yang G., Xiao X., Rosen D., Cheng X., Wu X., Chang B., Liu G., Xue F., Mercado-Uribe I., Chiao P.J., Du X., Liu J. The biphasic role of NF-{kappa}B in tumor progression and chemoresistance of ovarian cancer. Clin. Cancer Res. 2011, 10.1158/1078-0432.CCR-10-3265.
70. Yin X.M. Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes. J. Mol. Med. 2000, 78:203-211.
71. Zeini M., Hortelano S., Traves P.G., Gomez-Valades A.G., Pujol A., Perales J.C., Bartrons R., Bosca L. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation. FASEB J. 2005, 19:995-997.
72. Zhao Y., Ding W.X., Qian T., Watkins S., Lemasters J.J., Yin X.M. Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 2003, 125:854-867.
73. Zhao Y., Li S., Childs E.E., Kuharsky D.K., Yin X.M. Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-alpha-induced liver injury. J. Biol. Chem. 2001, 276:27432-27440.